For the Inventor, By the Inventor

Enter assignee name

Cambridge, MA, United States of America

Rubius Therapeutics, Inc.

USPTO Granted Patents = 16

EPO Patents = 3

Trademarks = 7

Forward Citations = 121

Loading Chart...

Loading Chart...

18 inventors (with patents filed for the assignee):

Jordi Mata-Fink (15 out of 26 patents)

Avak Kahvejian (14 out of 30 patents)

John Round (14 out of 14 patents)

4. Noubar Boghos Afeyan (14 out of 77 patents)

5. David Arthur Berry (7 out of 84 patents)

6. Sivan Elloul (6 out of 6 patents)

7. Tom Wickham (5 out of 5 patents)

8. Tiffany F Chen (5 out of 5 patents)

9. Robert J Deans (4 out of 17 patents)

10. Torben Straight Nissen (4 out of 4 patents)

11. Nathan Dowden (4 out of 4 patents)

12. Lenka Hoffman (1 out of 4 patents)

13. Thomas Joseph Wickham (1 out of 15 patents)

14. Xuqing Zhang (1 out of 1 patent)

15. Carolyn Sayre (1 out of 1 patent)

16 patents: Sort by Forward Citations

1. 11576934 - Methods and compositions for immunomodulation (2023-02-14),

2. 11554141 - Methods and compositions for immunomodulation (2023-01-17),

3. 11141433 - Therapeutic cell systems and methods for treating cancer and infectious diseases (2021-10-12),

4. 11020435 - Functionalized erythroid cells (2021-06-01),

5. 10869898 - Methods and compositions for immunomodulation (2020-12-22),

6. 10716811 - Compositions and methods related to multimodal therapeutic cancer indications (2020-07-21),

7. 10568910 - Compositions and methods related to engineered erythroid cells comprising IL-15 (2020-02-25),

8. 10557119 - Erythroid cells comprising phenylalanine ammonia lyase (2020-02-11),

9. 10517897 - Methods related to engineered erythoid cells comprising 4-1BBL (2019-12-31),

10. 10456421 - Compositions and methods related to engineered erythoid cells comprising 4-1BBL (2019-10-29),

11. 10344263 - Synthetic membrane-receiver complexes (2019-07-09),

12. 10329531 - Synthetic membrane-receiver complexes (2019-06-25),

13. 10301594 - Synthetic membrane-receiver complexes (2019-05-28),

14. 10301593 - Synthetic membrane-receiver complexes (2019-05-28),

15. 10253296 - Synthetic membrane-receiver complexes (2019-04-09),

Rubius Therapeutics is a biopharmaceutical company that is developing a new class of medicines called Red Cell Therapeutics. By genetically engineering red blood cells, Rubius aims to create cellular therapies to treat various diseases, including cancer, autoimmune disorders, and metabolic diseases.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

16 Patents

#138 in Cambridge, MA

#1,160 in Massachusetts

#19,271 in US

#36,634 in the World

Cambridge, MA, United States of America

Rubius Therapeutics, Inc.

Forward Citations = 121

18 inventors:

Jordi Mata-Fink (15 out of 26 patents)

Avak Kahvejian (14 out of 30 patents)

John Round (14 out of 14 patents)

4. Noubar Boghos Afeyan (14 out of 77 patents)

5. David Arthur Berry (7 out of 84 patents)

Please report any incorrect information to support@idiyas.com

Loading…